Prime Screen Multi-Drug Urine Test Cup 16 Panel Kit Instruction Manual

1. Introduction

This instruction manual provides detailed guidance for the proper use of the Prime Screen Multi-Drug Urine Test Cup 16 Panel Kit. This kit is a rapid, qualitative immunoassay for the simultaneous detection of 16 specific drugs and their metabolites in human urine. It is intended for in vitro diagnostic use only.

The 16 panels detected include: Amphetamine (AMP), Secobarbital (BAR), Buprenorphine (BUP), Oxazepam (BZO), Cocaine (COC), Methylenedioxymethamphetamine (MDMA), Methamphetamine (mAMP), Morphine (MOP/OPI), Methadone (MTD), Oxycodone (OXY), Phencyclidine (PCP), Cannabinoids (THC), Alcohol (ETG), Fentanyl (FTY), Tramadol (TRA), and Synthetic Cannabinoid (K2).

2. Safety Precautions

• For in vitro diagnostic use only. Do not ingest.
• Do not use the test cup after its expiration date, which is printed on the packaging.
• Handle all urine specimens as potentially infectious. Wear appropriate personal protective equipment, such as disposable gloves, during collection and handling.
• Keep the test kit out of reach of children.
• This test provides a preliminary analytical result. A secondary analytical method, such as Gas Chromatography/Mass Spectrometry (GC/MS), must be used to confirm any preliminary positive result.
• Statements regarding this product have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.

3. Product Components

Each Prime Screen Multi-Drug Urine Test Cup kit typically includes:

• One (1) Multi-Drug Urine Test Cup with integrated test strips.
• One (1) Disposable plastic glove.

The test cup features a leak-proof design and an integrated temperature strip to help verify specimen integrity immediately after collection.

Image 3.1: An exploded view of the Prime Screen urine test cup, highlighting its leak-proof design and the integrated temperature strip for verifying specimen integrity.

4. Setup

1. Ensure the test cup is at room temperature (15-30°C / 59-86°F) before use. Cold samples or cups may affect test accuracy.
2. Gather all necessary materials, including the test cup, disposable gloves, and a timer.
3. Open the sealed pouch and remove the test cup. Do not use if the pouch is damaged or opened.

5. Operating Instructions

5.1 Specimen Collection

1. Put on the disposable plastic gloves provided.
2. Remove the cap from the test cup.
3. Collect urine directly into the test cup. Ensure the urine volume reaches at least the minimum fill line indicated on the cup.
4. Immediately after collection (within 2-4 minutes), check the temperature strip on the side of the cup. The temperature should be within the acceptable range (typically 90-100°F or 32-38°C) to confirm specimen validity.

5.2 Testing Procedure

1. Securely recap the test cup, ensuring it is tightly sealed to prevent leaks.
2. Place the test cup on a clean, flat surface.
3. Start a timer for exactly 5 minutes.
4. Do not move or disturb the cup during the 5-minute development period.

Image 5.1: A visual instruction guide showing the three simple steps for using the test cup: 1. Collect the urine sample, 2. Securely recap the cup and wait for 5 minutes, and 3. Peel the label to reveal the test strips and read the results.

5.3 Result Interpretation

1. At exactly 5 minutes, peel off the label on the front of the cup to reveal the test strips.
2. Interpret the results for each drug panel. Important: Do not interpret results after 5 minutes, as this may lead to inaccurate readings.

Image 5.2: An illustration demonstrating how to interpret test results, showing examples of a Negative result (two lines), a Preliminary Positive result (one control line), and an Invalid result (no lines or only a test line).

6. Result Interpretation Details

6.1 Negative Result

A negative result is indicated by the appearance of two distinct colored lines: one in the Control region (C) and another in the Test region (T). The intensity of the line in the Test region (T) may vary. Even a faint line in the Test region (T) should be interpreted as a negative result.

6.2 Preliminary Positive Result

A preliminary positive result is indicated by the appearance of only one colored line in the Control region (C). No line appears in the Test region (T). This suggests that the drug concentration in the urine sample is at or above the cut-off level for that specific drug.

6.3 Invalid Result

An invalid result occurs if no colored line appears in the Control region (C), or if only a line appears in the Test region (T) without a Control line. An invalid result indicates insufficient specimen volume or incorrect procedural techniques. In such cases, the test should be repeated using a new test cup.

7. Detection Information

The following table provides details on the drugs detected, their identifiers, calibrators, cut-off levels, and approximate detection times.

Image 7.1: A comprehensive table listing the 16 drugs detected by the test, their identifiers (e.g., AMP, THC), calibrators, specific cut-off levels in ng/mL, and the minimum and maximum detection times in hours and days.

7.1 Cut-off Level

The cut-off level is the concentration of a substance in a urine sample. Any concentration above the cut-off level is considered a preliminary positive result, and vice versa.

7.2 Detection Window

The detection window refers to the approximate length of time that a urine test can detect the presence of a given substance after use. This can vary based on individual metabolism, dosage, frequency of use, and other factors.

8. Troubleshooting

• No lines appear or only a Test line (T) appears: This indicates an invalid result. Ensure sufficient urine volume was collected and the procedure was followed correctly. Repeat the test with a new test cup.
• Faint line in the Test region (T): A faint line, regardless of its intensity, is still considered a negative result.
• Results not appearing after 5 minutes: Ensure the timer was set correctly. Do not interpret results after 5 minutes, as they may become inaccurate.
• Temperature strip indicates out of range: The specimen may not be valid. Collect a new sample.

9. Maintenance

The Prime Screen Multi-Drug Urine Test Cup requires minimal maintenance. To ensure optimal performance and accuracy:

• Store the test cups in their original sealed pouches at room temperature (15-30°C / 59-86°F).
• Protect from moisture, direct sunlight, and freezing.
• Do not open the foil pouch until immediately before use.

10. Specifications

• Product Name: Prime Screen Multi-Drug Urine Test Cup 16 Panel Kit
• Model Number: CDOA-9165EFTK
• Manufacturer: Wondfo
• ASIN: B08BBKVLNR
• Package Dimensions: 5.75 x 5.2 x 2.72 inches
• Item Weight: 1.45 ounces
• Date First Available: June 16, 2020
• Detected Substances: Amphetamine (AMP), Secobarbital (BAR), Buprenorphine (BUP), Oxazepam (BZO), Cocaine (COC), Methylenedioxymethamphetamine (MDMA), Methamphetamine (mAMP), Morphine (MOP/OPI), Methadone (MTD), Oxycodone (OXY), Phencyclidine (PCP), Cannabinoids (THC), Alcohol (ETG), Fentanyl (FTY), Tramadol (TRA), Synthetic Cannabinoid (K2).

11. Warranty Information

Specific warranty information for the Prime Screen Multi-Drug Urine Test Cup 16 Panel Kit is not provided in the available product data. Please refer to the product packaging or contact the manufacturer directly for warranty details.

12. Support and Contact

For further assistance, questions, or to report any issues with your Prime Screen Multi-Drug Urine Test Cup, please contact the manufacturer, Wondfo, or the seller from whom the product was purchased. Contact information may be available on the product packaging or through the seller's customer service channels.